Approval · Notice of Compliance 8059 · 2006
TOPILOX: Notice of Compliance 8059
Issued June 20, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8059
- Date
- June 20, 2006
- Company
- Les Laboratoires NovichemBrossard, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antiepileptic / migraine prophylaxis
- Canadian reference product
- TOPAMAX (Janssen-Ortho Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOPILOX | 02281740 | — |
| TOPILOX | 02281759 | — |
| TOPILOX | 02281767 | — |
Medicinal ingredients
- TOPIRAMATE 25 MG per TAB
- TOPIRAMATE 100 MG per TAB
- TOPIRAMATE 200 MG per TAB